GlassScriptPhysician profile
Jeffery Bowers
NPI 1013958552
$1,027.75
in general payments reported to CMS, 2019-2025
20 companies · $276 in 2025
The $276 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $565 · 2020: $129 · 2023: $17.04 · 2024: $39.53 · 2025: $276.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $333.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $333.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $263.54 | 2019-2025 | Ozempic, Rybelsus |
| Glaxosmithkline, LLC. | $123.81 | 2019-2025 | Shingrix |
| Lilly USA, LLC | $104.12 | 2019-2025 | Zepbound, Mounjaro |
| Pfizer INC. | $88.05 | 2019-2025 | |
| Amarin Pharma, INC. | $67.96 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $64.20 | 2019-2025 | Airsupra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $58.51 | 2019-2025 | Jardiance |
| Takeda Pharmaceuticals U.S.A., INC. | $48.18 | 2019-2020 | |
| Astellas Pharma US INC | $39.38 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $23.12 | 2019-2020 | |
| Exact Sciences Corporation | $18.12 | 2025 | The Cologuard Plus Collection Kit |
| Abbvie INC. | $17.04 | 2023 | Vraylar |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.03 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $15.10 | 2025 | Zoryve |
| Valeritas, INC. | $15.06 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $14.40 | 2025 | Minimed 780g |
| Amgen INC. | $13.50 | 2019 | |
| Janssen Pharmaceuticals, INC | $13.10 | 2019 | |
| Ironshore Pharmaceuticals INC. | $12.45 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $11.08 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffery Bowers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.